Use of Corticosteroids in COVID-19: Should It Be Considered as a Standard-of-Care Therapy?

Simple item page
dc.contributor.authorRoessler, Patricia
dc.contributor.authorRoizen, Gigia
dc.contributor.authorValenzuela, Omar
dc.contributor.authorIbáñez, Sebastián
dc.date.accessioned2021-08-17T20:36:52Z
dc.date.available2021-08-17T20:36:52Z
dc.date.issued2020
dc.description.abstractBy the end of 2019, a novel coronavirus was identified as the cause of several cases of pneumonia in Wuhan, China. Its appearance was rapidly evident throughout the world. In February 2020, the World Health Organization (WHO) designated the disease as coronavirus disease 2019 (COVID-19). The virus that causes COVID-19 is named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and it has been responsible of more than 1,200,000 deaths in the world to date.1,2 Until a vaccine or other effective treatment is available, the pandemic has created the urgent need to repurpose different therapeutic tools to stop the disease. In this context, corticosteroids (CSs) emerge as a highly available and known therapeutic alternative worldwide. Corticosteroids had been used in the setting of previous severe coronavirus infection, including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) with controversial results. SARS-CoV-2, SARS-CoV, and MERS-CoV share many genetic features, and SARS-CoV-2 is highly homologous to SARS-CoV.3 We will discuss the mechanism of action of CSs, and we will critically review the current literature to analyze the arguments against and in favor of using this therapy in COVID-19es
dc.description.versionVersión Publicada
dc.identifier.citationRoessler P., Roizen G., Ibañez S., Valenzuela O. Use of Corticosteroids in COVID-19: Should it be considered as a Standard-of-Care Therapy. Journal of Clinical Rheumatology. Volume 27, Number 2, March 2021es
dc.identifier.urihttps://dx.doi.org/10.1097/RHU.0000000000001701es
dc.identifier.urihttp://hdl.handle.net/11447/4348
dc.language.isoenes
dc.sourceJournal of Clinical Rheumatology
dc.titleUse of Corticosteroids in COVID-19: Should It Be Considered as a Standard-of-Care Therapy?es
dc.typeArticlees

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Use of Corticosteroids in COVID-19 Should It Be Considered as a Standard-of-Care Therapy.pdf
Size:
101.9 KB
Format:
Adobe Portable Document Format
Description:
Texto completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services